ABSTRACT
Diseases with different pathogeneses share common pathways of immune-mediated injury. Autoreactive T cells destroy hepatocytes or cholangiocytes in autoimmune disease and virus-specific T cells destroy infected hepatocytes in viral hepatitis. In these conditions, antigen-specific mechanisms can be implicated but immune-mediated injury is central to diseases where there is a less-defined role for specific antigens. In all these diseases, “bystander cells” activated by the local microenvironment rather than a specific antigen are major players and amplify effector responses by recruiting natural killer and natural killer T cells, macrophages, neutrophils, eosinophils, and even platelets. Immune-mediated liver injury is driven by repeated cycles of inflammation and damage sustained by continuing recruitment, retention, and survival of effector leukocytes within the inflamed liver. These processes depend on complex interactions involving epithelial cells, stromal cells, and leukocytes shaped by the local cytokine microenvironment. Understanding these interactions will elucidate the pathogenesis of liver disease and suggest new therapies.
KEYWORDS
Inflammation - hepatitis - cell trafficking - chemokines - TNF - CD40
REFERENCES
1
Crispe I N, Giannandrea M, Klein I, John B, Sampson B, Wuensch S.
Cellular and molecular mechanisms of liver tolerance.
Immunol Rev.
2006;
213
101-118
2
Sakaguchi S.
Naturally arising CD4 + regulatory T cells for immunologic self-tolerance and negative control of immune responses.
Annu Rev Immunol.
2004;
22
531-562
3
Knolle P A, Limmer A.
Neighborhood politics: the immunoregulatory function of organ-resident liver endothelial cells.
Trends Immunol.
2001;
22
432-437
4
Bowen D G, McCaughan G W, Bertolino P.
Intrahepatic immunity: a tale of two sites?.
Trends Immunol.
2005;
26
512-517
5
Willberg C, Barnes E, Klenerman P.
HCV immunology-death and the maiden T cell.
Cell Death Differ.
2003;
10(suppl 1)
S39-47
6
Kyewski B, Klein L.
A central role for central tolerance.
Annu Rev Immunol.
2006;
24
571-606
7
Ruprecht C R, Gattorno M, Ferlito F et al..
Coexpression of CD25 and CD27 identifies FoxP3 + regulatory T cells in inflamed synovia.
J Exp Med.
2005;
201
1793-1803
8
Seddiki N, Santner-Nanan B, Martinson J et al..
Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells.
J Exp Med.
2006;
203
1693-1700
9
Huehn J, Siegmund K, Lehmann J C et al..
Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4 + regulatory T cells.
J Exp Med.
2004;
199
303-313
10
Agarwal K, Czaja A J, Jones D E, Donaldson P T.
Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis.
Hepatology.
2000;
31
49-53
11
Longhi M S, Hussain M J, Mitry R R et al..
Functional study of CD4 + CD25 + regulatory T cells in health and autoimmune hepatitis.
J Immunol.
2006;
176
4484-4491
12
Rushbrook S M, Ward S M, Unitt E et al..
Regulatory T cells suppress in vitro proliferation of virus-specific CD8 + T cells during persistent hepatitis C virus infection.
J Virol.
2005;
79
7852-7859
13
Unitt E, Rushbrook S M, Marshall A et al..
Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells.
Hepatology.
2005;
41
722-730
14
Eksteen B, Miles A, Curbishley S M et al..
Epithelial inflammation is associated with CCL28 production and the recruitment of regulatory T cells expressing CCR10.
J Immunol.
2006;
177
593-603
15
Kakimi K, Lane T E, Wieland S et al..
Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes.
J Exp Med.
2001;
194
1755-1766
16
Curbishley S M, Eksteen B, Gladue R P, Lalor P, Adams D H.
CXCR3 activation promotes lymphocyte transendothelial migration across human hepatic endothelium under fluid flow.
Am J Pathol.
2005;
167
887-899
17
Lan R Y, Cheng C, Lian Z X et al..
Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis.
Hepatology.
2006;
43
729-737
18
Erhardt A, Biburger M, Papadopoulos T, Tiegs G.
IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice.
Hepatology.
2007;
45
475-485
19
Wiegard C, Frenzel C, Herkel J, Kallen K J, Schmitt E, Lohse A W.
Murine liver antigen presenting cells control suppressor activity of CD4 + CD25 + regulatory T cells.
Hepatology.
2005;
42
193-199
20
Westendorf A M, Templin M, Geffers R et al..
CD4 + T cell mediated intestinal immunity: chronic inflammation versus immune regulation.
Gut.
2005;
54
60-69
21
Doherty D G, Norris S, Madrigal-Estebas L et al..
The human liver contains multiple populations of NK cells, T cells, and CD3 + CD56 + natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns.
J Immunol.
1999;
163
2314-2321
22
Kronenberg M, Rudensky A.
Regulation of immunity by self-reactive T cells.
Nature.
2005;
435
598-604
23
Ajuebor M N, Hogaboam C M, Le T, Swain M G.
C-C chemokine ligand 2/monocyte chemoattractant protein-1 directly inhibits NKT cell IL-4 production and is hepatoprotective in T cell-mediated hepatitis in the mouse.
J Immunol.
2003;
170
5252-5259
24
Ajuebor M N, Aspinall A I, Zhou F et al..
Lack of chemokine receptor CCR5 promotes murine fulminant liver failure by preventing the apoptosis of activated CD1d-restricted NKT cells.
J Immunol.
2005;
174
8027-8037
25
Goddard S, Youster J, Morgan E, Adams D H.
Interleukin-10 secretion differentiates dendritic cells from human liver and skin.
Am J Pathol.
2004;
164
511-519
26
Lian Z X, Okada T, He X S et al..
Heterogeneity of dendritic cells in the mouse liver: identification and characterization of four distinct populations.
J Immunol.
2003;
170
2323-2330
27
Bowen D G, Zen M, Holz L, Davis T, McCaughan G W, Bertolino P.
The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity.
J Clin Invest.
2004;
114
701-712
28
Kudo S, Matsuno K, Ezaki T, Ogawa M.
A novel migration pathway for rat dendritic cells from the blood: hepatic sinusoids-lymph translocation.
J Exp Med.
1997;
185
777-784
29
Yoneyama H, Matsuno K, Zhang Y et al..
Regulation by chemokines of circulating dendritic cell precursors, and the formation of portal tract-associated lymphoid tissue, in a granulomatous liver disease.
J Exp Med.
2001;
193
35-49
30
Bosma B M, Metselaar H J, Mancham S et al..
Characterization of human liver dendritic cells in liver grafts and perfusates.
Liver Transpl.
2006;
12
384-393
31
Warren A, Le Couteur D G, Fraser R, Bowen D G, McCaughan G W, Bertolino P.
T lymphocytes interact with hepatocytes through fenestrations in murine liver sinusoidal endothelial cells.
Hepatology.
2006;
44
1182-1190
32
Limmer A, Ohl J, Kurts C et al..
Efficient presentation of exogenous antigen by liver endothelial cells to CD8 + T cells results in antigen-specific T-cell tolerance.
Nat Med.
2000;
6
1348-1354
33
Klugewitz K, Blumenthal-Barby F, Schrage A, Knolle P A, Hamann A, Crispe I N.
Immunomodulatory effects of the liver: deletion of activated CD4 + effector cells and suppression of IFN-gamma-producing cells after intravenous protein immunization.
J Immunol.
2002;
169
2407-2413
34
Limmer A, Ohl J, Wingender G et al..
Cross-presentation of oral antigens by liver sinusoidal endothelial cells leads to CD8 T cell tolerance.
Eur J Immunol.
2005;
35
2970-2981
35
Klein I, Crispe I N.
Complete differentiation of CD8 + T cells activated locally within the transplanted liver.
J Exp Med.
2006;
203
437-447
36
John B, Klein I, Crispe I N.
Immune role of hepatic TLR-4 revealed by orthotopic mouse liver transplantation.
Hepatology.
2007;
45
178-186
37
Iwai Y, Terawaki S, Ikegawa M, Okazaki T, Honjo T.
PD-1 inhibits antiviral immunity at the effector phase in the liver.
J Exp Med.
2003;
198
39-50
38
Klugewitz K, Adams D H, Emoto M, Eulenburg K, Hamann A.
The composition of intrahepatic lymphocytes: shaped by selective recruitment?.
Trends Immunol.
2004;
25
590-594
39
Butcher E C, Picker L J.
Lymphocyte homing and homeostasis.
Science.
1996;
272
60-66
40
Wong J, Johnston B, Lee S S et al..
A minimal role for selectins in the recruitment of leukocytes into the inflamed liver microvasculature.
J Clin Invest.
1997;
99
2782-2790
41
Campbell J J, Qin S, Bacon K B, Mackay C R, Butcher E C.
Biology of chemokine and classical chemoattractant receptors: differential requirements for adhesion-triggering versus chemotactic responses in lymphoid cells.
J Cell Biol.
1996;
134
255-266
42
Lalor P F, Shields P, Grant A, Adams D H.
Recruitment of lymphocytes to the human liver.
Immunol Cell Biol.
2002;
80
52-64
43
Adams D H, Eksteen B.
Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease.
Nat Rev Immunol.
2006;
6
244-251
44
Lalor P H, Faint J, Aarbodem Y, Hubscher S G, Adams D H.
The role of cytokines and chemokines in the development of steatohepatitis.
Semin Liver Dis.
2007;
27
173-193
45
Desmet V J, Gerber M, Hoofnagle J H, Manns M, Scheuer P J.
Classification of chronic hepatitis: diagnosis, grading and staging.
Hepatology.
1994;
19
1513-1520
46
Steinhoff G, Behrend M, Schrader B, Duijvestijn A M, Wonigeit K.
Expression patterns of leukocyte adhesion ligand molecules on human liver endothelia-lack of ELAM-1 and CD62 inducibility on sinusoidal endothelia and distinct distribution of VCAM-1, ICAM-1, ICAM-2 and LFA-3.
Am J Pathol.
1993;
142
481-488
47
Lalor P F, Lai W K, Curbishley S M, Shetty S, Adams D H.
Human hepatic sinusoidal endothelial cells can be distinguished by expression of phenotypic markers related to their specialised functions in vivo.
World J Gastroenterol.
2006;
12
5429-5439
48
McNab G, Reeves J L, Salmi M, Hubscher S, Jalkanen S, Adams D H.
Vascular adhesion protein 1 mediates binding of T cells to human hepatic endothelium.
Gastroenterology.
1996;
110
522-528
49
Lalor P F, Sun P J, Weston C J, Martin-Santos A, Wakelam M J, Adams D H.
Activation of vascular adhesion protein-1 on liver endothelium results in an NF-kappaB-dependent increase in lymphocyte adhesion.
Hepatology.
2007;
45
465-474
50
Lalor P F, Edwards S, McNab G, Salmi M, Jalkanen S, Adams D H.
Vascular adhesion protein-1 mediates adhesion and transmigration of lymphocytes on human hepatic endothelial cells.
J Immunol.
2002;
169
983-992
51
Bonder C S, Norman M U, Swain M G et al..
Rules of recruitment for Th1 and Th2 lymphocytes in inflamed liver: a role for alpha-4 integrin and vascular adhesion protein-1.
Immunity.
2005;
23
153-163
52
Boisvert J, Kunkel E J, Campbell J J, Keeffe E B, Butcher E C, Greenberg H B.
Liver-infiltrating lymphocytes in end-stage hepatitis C virus: subsets, activation status, and chemokine receptor phenotypes.
J Hepatol.
2003;
38
67-75
53
Shields P L, Morland C M, Salmon M, Qin S, Hubscher S G, Adams D H.
Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver.
J Immunol.
1999;
163
6236-6243
54
Murai M, Yoneyama H, Harada A et al..
Active participation of CCR5( + )CD8( + ) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease.
J Clin Invest.
1999;
104
49-57
55
Ajuebor M N, Hogaboam C M, Le T, Proudfoot A E, Swain M G.
CCL3/MIP-1alpha is pro-inflammatory in murine T cell-mediated hepatitis by recruiting CCR1-expressing CD4( + ) T cells to the liver.
Eur J Immunol.
2004;
34
2907-2918
56
Harvey C E, Post J J, Palladinetti P et al..
Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation.
J Leukoc Biol.
2003;
74
360-369
57
Geissmann F, Cameron T O, Sidobre S et al..
Intravascular immune surveillance by CXCR6 + NKT cells patrolling liver sinusoids.
PLoS Biol.
2005;
3
e113
58
Heydtmann M, Lalor P F, Eksteen J A, Hubscher S G, Briskin M, Adams D H.
CXC chemokine ligand 16 promotes integrin-mediated adhesion of liver-infiltrating lymphocytes to cholangiocytes and hepatocytes within the inflamed human liver.
J Immunol.
2005;
174
1055-1062
59
Probert C S, Christ A D, Saubermann L J et al..
Analysis of human common bile duct-associated T cells: evidence for oligoclonality, T cell clonal persistence, and epithelial cell recognition.
J Immunol.
1997;
158
1941-1948
60
Adams D H, Afford S C.
Effector mechanisms of nonsuppurative destructive cholangitis in graft-versus-host disease and allograft rejection.
Semin Liver Dis.
2005;
25
281-297
61
Nishio A, Keeffe E B, Gershwin M E.
Immunopathogenesis of primary biliary cirrhosis.
Semin Liver Dis.
2002;
22
291-302
62
O'Mahony C A, Vierling J M.
Etiopathogenesis of primary sclerosing cholangitis.
Semin Liver Dis.
2006;
26
3-21
63
Morland C M, Fear J, McNab G, Joplin R, Adams D H.
Promotion of leukocyte transendothelial cell migration by chemokines derived from human biliary epithelial cells in vitro.
Proc Assoc Am Physicians.
1997;
109
372-382
64
Leon M P, Bassendine M F, Wilson J L, Ali S, Thick M, Kirby J A.
Immunogenicity of biliary epithelium: investigation of antigen presentation to CD4 + T cells.
Hepatology.
1996;
24
561-567
65
Chen X M, O'Hara S P, Nelson J B et al..
Multiple TLRs are expressed in human cholangiocytes and mediate host epithelial defense responses to Cryptosporidium parvum via activation of NF-kappaB.
J Immunol.
2005;
175
7447-7456
66
Isse K, Harada K, Zen Y et al..
Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts.
Hepatology.
2005;
41
506-516
67
Efsen E, Grappone C, Defranco R M et al..
Up-regulated expression of fractalkine and its receptor CX3CR1 during liver injury in humans.
J Hepatol.
2002;
37
39-47
68
Wilbanks A, Zondlo S C, Murphy K et al..
Expression cloning of the strl33/bonzo/tymstr ligand reveals elements of cc, cxc, and cx3c chemokines.
J Immunol.
2001;
166
5145-5154
69
Kim C H, Kunkel E J, Boisvert J et al..
Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential.
J Clin Invest.
2001;
107
595-601
70
Sato T, Thorlacius H, Johnston B et al..
Role for CXCR6 in recruitment of activated CD8 + lymphocytes to inflamed liver.
J Immunol.
2005;
174
277-283
71
Drayton D L, Liao S, Mounzer R H, Ruddle N H.
Lymphoid organ development: from ontogeny to neogenesis.
Nat Immunol.
2006;
7
344-353
72
Yoneyama H, Ichida T.
Recruitment of dendritic cells to pathological niches in inflamed liver.
Med Mol Morphol.
2005;
38
136-141
73
Grant A J, Goddard S, Ahmed-Choudhury J et al..
Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease.
Am J Pathol.
2002;
160
1445-1455
74
Murakami J, Shimizu Y, Kashii Y et al..
Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.
Hepatology.
1999;
30
143-150
75
Pope C, Kim S K, Marzo A et al..
Organ-specific regulation of the CD8 T cell response to Listeria monocytogenes infection.
J Immunol.
2001;
166
3402-3409
76
Agace W W.
Tissue-tropic effector T cells: generation and targeting opportunities.
Nat Rev Immunol.
2006;
6
682-692
77
Eksteen B, Grant A J, Miles A et al..
Hepatic endothelial CCL25 mediates the recruitment of CCR9 + gut-homing lymphocytes to the liver in primary sclerosing cholangitis.
J Exp Med.
2004;
200
1511-1517
78
Grant A J, Lalor P F, Hubscher S G, Briskin M, Adams D H.
MAdCAM-1 expressed in chronic inflammatory liver disease supports mucosal lymphocyte adhesion to hepatic endothelium (MAdCAM-1 in chronic inflammatory liver disease).
Hepatology.
2001;
33
1065-1072
79
Mora J R, Iwata M, Eksteen B et al..
Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells.
Science.
2006;
314
1157-1160
80
Murai M, Yoneyama H, Ezaki T et al..
Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction.
Nat Immunol.
2003;
4
154-160
81
Petrovic A, Alpdogan O, Willis L M et al..
LPAM (alpha 4 beta 7 integrin) is an important homing integrin on alloreactive T cells in the development of intestinal graft-versus-host disease.
Blood.
2004;
103
1542-1547
82
Henkart P A.
CTL effector functions.
Semin Immunol.
1997;
9
85-86
83
Guicciardi M E, Gores G J.
Cheating death in the liver.
Nat Med.
2004;
10
587-588
84
Abougergi M S, Gidner S J, Spady D K, Miller B C, Thiele D L.
Fas and TNFR1, but not cytolytic granule-dependent mechanisms, mediate clearance of murine liver adenoviral infection.
Hepatology.
2005;
41
97-105
85
Kafrouni M I, Brown G R, Thiele D L.
Virally infected hepatocytes are resistant to perforin-dependent CTL effector mechanisms.
J Immunol.
2001;
167
1566-1574
86
Tilg H, Diehl A M.
Cytokines in alcoholic and nonalcoholic steatohepatitis.
N Engl J Med.
2000;
343
1467-1476
87
Tsukamoto H, Lu S C.
Current concepts in the pathogenesis of alcoholic liver injury.
FASEB J.
2001;
15
1335-1349
88
Li Z, Lin H, Yang S, Diehl A M.
Murine leptin deficiency alters Kupffer cell production of cytokines that regulate the innate immune system.
Gastroenterology.
2002;
123
1304-1310
89
Fox-Robichaud A, Kubes P.
Molecular mechanisms of tumor necrosis factor alpha-stimulated leukocyte recruitment into the murine hepatic circulation.
Hepatology.
2000;
31
1123-1127
90
Wolf D, Hallmann R, Sass G et al..
TNF-alpha-induced expression of adhesion molecules in the liver is under the control of TNFR1-relevance for concanavalin A-induced hepatitis.
J Immunol.
2001;
166
1300-1307
91
Wang Y, Singh R, Lefkowitch J H, Rigoli R M, Czaja M J.
Tumor necrosis factor-induced toxic liver injury results from JNK2-dependent activation of caspase-8 and the mitochondrial death pathway.
J Biol Chem.
2006;
281
15258-15267
92
Schwabe R F, Brenner D A.
Mechanisms of liver injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways.
Am J Physiol Gastrointest Liver Physiol.
2006;
290
G583-G589
93
Alpini G, Ueno Y, Tadlock L et al..
Increased susceptibility of cholangiocytes to tumor necrosis factor-alpha cytotoxicity after bile duct ligation.
Am J Physiol Cell Physiol.
2003;
285
C183-C194
94
Streetz K, Leifeld L, Grundmann D et al..
Tumor necrosis factor alpha in the pathogenesis of human and murine fulminant hepatic failure.
Gastroenterology.
2000;
119
446-460
95
Plumpe J, Malek N P, Bock C T, Rakemann T, Manns M P, Trautwein C.
NF-kappaB determines between apoptosis and proliferation in hepatocytes during liver regeneration.
Am J Physiol Gastrointest Liver Physiol.
2000;
278
G173-G183
96
Liedtke C, Trautwein C.
A protective role of Stat3 in Fas mediated apoptosis of the liver.
J Hepatol.
2004;
40
874-875
97
Luedde T, Trautwein C.
Intracellular survival pathways in the liver.
Liver Int.
2006;
26
1163-1174
98
Afford S C, Randhawa S, Eliopoulos A G, Hubscher S G, Young L S, Adams D H.
CD40 activation induces apoptosis in cultured human hepatocytes via induction of cell surface fas ligand expression and amplifies fas-mediated hepatocyte death during allograft rejection.
J Exp Med.
1999;
189
441-446
99
Grell M, Zimmermann G, Gottfried E et al..
Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF.
EMBO J.
1999;
18
3034-3043
100
Afford S C, Ahmed-Choudhury J, Randhawa S et al..
CD40 activation-induced, Fas-dependent apoptosis and NF-kappaB/AP-1 signaling in human intrahepatic biliary epithelial cells.
FASEB J.
2001;
15
2345-2354
101
Ahmed-Choudhury J, Russell C L, Randhawa S et al..
Differential induction of nuclear factor-kappaB and activator protein-1 activity after CD40 ligation is associated with primary human hepatocyte apoptosis or intrahepatic endothelial cell proliferation.
Mol Biol Cell.
2003;
14
1334-1345
102
Kusters S, Tiegs G, Alexopoulou L et al..
In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis.
Eur J Immunol.
1997;
27
2870-2875
103
Ahmed-Choudhury J, Williams K T, Young L S, Adams D H, Afford S C.
CD40 mediated human cholangiocyte apoptosis requires JAK2 dependent activation of STAT3 in addition to activation of JNK1/2 and ERK1/2.
Cell Signal.
2006;
18
456-468
104
Bonizzi G, Karin M.
The two NF-kappaB activation pathways and their role in innate and adaptive immunity.
Trends Immunol.
2004;
25
280-288
105
Guillonneau C, Louvet C, Renaudin K et al..
The role of TNF-related activation-induced cytokine-receptor activating NF-kappa B interaction in acute allograft rejection and CD40L-independent chronic allograft rejection.
J Immunol.
2004;
172
1619-1629
106
Mehling A, Loser K, Varga G et al..
Overexpression of CD40 ligand in murine epidermis results in chronic skin inflammation and systemic autoimmunity.
J Exp Med.
2001;
194
615-628
107
Kiener P A, Moran-Davis P, Rankin B M, Wahl A F, Aruffo A, Hollenbaugh D.
Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes.
J Immunol.
1995;
155
4917-4925
108
Yellin M J, Winikoff S, Fortune S M et al..
Ligation of CD40 on fibroblasts induces CD54 (ICAM-1) and CD106 (VCAM-1) up-regulation and IL-6 production and proliferation.
J Leukoc Biol.
1995;
58
209-216
109
Zhou F, Ajuebor M N, Beck P L, Le T, Hogaboam C M, Swain M G.
CD154-CD40 interactions drive hepatocyte apoptosis in murine fulminant hepatitis.
Hepatology.
2005;
42
372-380
110
Brodeur S R, Angelini F, Bacharier L B et al..
C4b-binding protein (C4BP) activates B cells through the CD40 receptor.
Immunity.
2003;
18
837-848
111
Blom A M, Villoutreix B O, Dahlback B.
Complement inhibitor C4b-binding protein-friend or foe in the innate immune system?.
Mol Immunol.
2004;
40
1333-1346
112
Williams K T, Young S P, Negus A, Young L S, Adams D H, Afford S C.
C4b binding protein binds to CD154 preventing CD40 mediated cholangiocyte apoptosis: a novel link between complement and epithelial cell survival.
PLoS ONE..
2007;
2
e159
113
Diehl G E, Yue H H, Hsieh K et al..
TRAIL-R as a negative regulator of innate immune cell responses.
Immunity.
2004;
21
877-889
114
Liu Y G, Liu S X, Liang X H et al..
Blockade of TRAIL pathway ameliorates HBV-induced hepatocyte apoptosis in an acute hepatitis model.
Biochem Biophys Res Commun.
2007;
352
329-334
115
Liang X, Liu Y, Zhang Q et al..
Hepatitis B virus sensitizes hepatocytes to TRAIL-induced apoptosis through Bax.
J Immunol.
2007;
178
503-510
116
Mundt B, Wirth T, Zender L et al..
Tumour necrosis factor related apoptosis inducing ligand (TRAIL) induces hepatic steatosis in viral hepatitis and after alcohol intake.
Gut.
2005;
54
1590-1596
117
Maini M K, Boni C, Lee C K et al..
The role of virus-specific CD8( + ) cells in liver damage and viral control during persistent hepatitis B virus infection.
J Exp Med.
2000;
191
1269-1280
118
Dunn C, Brunetto M, Reynolds G et al..
Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage.
J Exp Med.
2007;
204
667-680
119
Kimberley F C, Screaton G R.
Following a TRAIL: update on a ligand and its five receptors.
Cell Res.
2004;
14
359-372
120
O'Connor G M, Hart O M, Gardiner C M.
Putting the natural killer cell in its place.
Immunology.
2006;
117
1-10
121
Sitia G, Isogawa M, Iannacone M, Campbell I L, Chisari F V, Guidotti L G.
MMPs are required for recruitment of antigen-nonspecific mononuclear cells into the liver by CTLs.
J Clin Invest.
2004;
113
1158-1167
122
Sitia G, Isogawa M, Kakimi K, Wieland S F, Chisari F V, Guidotti L G.
Depletion of neutrophils blocks the recruitment of antigen-nonspecific cells into the liver without affecting the antiviral activity of hepatitis B virus-specific cytotoxic T lymphocytes.
Proc Natl Acad Sci U S A.
2002;
99
13717-13722
123
Tough D F, Borrow P, Sprent J.
Induction of bystander T-cell proliferation by viruses and type-i interferon in-vivo.
Science.
1996;
272
1947-1950
124
Adams D H, Hubscher S G.
Systemic viral infections and collateral damage in the liver.
Am J Pathol.
2006;
168
1057-1059
125
Polakos N K, Cornejo J C, Murray D A et al..
Kupffer cell-dependent hepatitis occurs during influenza infection.
Am J Pathol.
2006;
168
1169-1178
126
Duchini A, Hendry R M, Redfield D C, Pockros P J.
Influenza infection in patients before and after liver transplantation.
Liver Transpl.
2000;
6
531-542
127
Mehal W Z, Juedes A E, Crispe I N.
Selective retention of activated CD8 + T cells by the normal liver.
J Immunol.
1999;
163
3202-3210
128
Ward S M, Jonsson J R, Sierro S et al..
Virus-specific CD8 + T lymphocytes within the normal human liver.
Eur J Immunol.
2004;
34
1526-1531
129
Klein C, Wustefeld T, Assmus U et al..
The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury.
J Clin Invest.
2005;
115
860-869
130
Gabay C, Kushner I.
Acute-phase proteins and other systemic responses to inflammation.
N Engl J Med.
1999;
340
448-454
131
Tilg H, Moschen A R.
Adipocytokines: mediators linking adipose tissue, inflammation and immunity.
Nat Rev Immunol.
2006;
6
772-783
132
Verma S, Li S H, Wang C H et al..
Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction.
Circulation.
2003;
108
736-740
133
Tsuchihashi S, Livhits M, Zhai Y, Busuttil R W, Araujo J A, Kupiec-Weglinski J W.
Basal rather than induced heme oxygenase-1 levels are crucial in the antioxidant cytoprotection.
J Immunol.
2006;
177
4749-4757
134
Poss K D, Tonegawa S.
Reduced stress defense in heme oxygenase 1-deficient cells.
Proc Natl Acad Sci U S A.
1997;
94
10925-10930
135
Tejima K, Arai M, Ikeda H et al..
Ischemic preconditioning protects hepatocytes via reactive oxygen species derived from Kupffer cells in rats.
Gastroenterology.
2004;
127
1488-1496
136
McNally S J, Harrison E M, Ross J A, Garden O J, Wigmore S J.
Curcumin induces heme oxygenase-1 in hepatocytes and is protective in simulated cold preservation and warm reperfusion injury.
Transplantation.
2006;
81
623-626
137
Sass G, Seyfried S, Parreira S M et al..
Cooperative effect of biliverdin and carbon monoxide on survival of mice in immune-mediated liver injury.
Hepatology.
2004;
40
1128-1135
138
Shen X D, Ke B, Zhai Y et al..
CD154-CD40 T-cell costimulation pathway is required in the mechanism of hepatic ischemia/reperfusion injury, and its blockade facilitates and depends on heme oxygenase-1 mediated cytoprotection.
Transplantation.
2002;
74
315-319
139
Yamashita K, Ollinger R, McDaid J et al..
Heme oxygenase-1 is essential for and promotes tolerance to transplanted organs.
FASEB J.
2006;
20
776-778
140
Prinz I, Zerrahn J, Kaufmann S H, Steinhoff U.
Promiscuous peptide recognition of an autoreactive CD8( + ) T-cell clone is responsible for autoimmune intestinal pathology.
J Autoimmun.
2002;
18
281-287
141
Yu J, Ip E, Dela P A et al..
COX-2 induction in mice with experimental nutritional steatohepatitis: role as pro-inflammatory mediator.
Hepatology.
2006;
43
826-836
142
Serhan C N, Brain S D, Buckley C D et al..
Resolution of inflammation: state of the art, definitions and terms.
FASEB J.
2007;
21
325-332
143
Levy B D, Clish C B, Schmidt B, Gronert K, Serhan C N.
Lipid mediator class switching during acute inflammation: signals in resolution.
Nat Immunol.
2001;
2
612-619
144
Henderson N C, Iredale J P.
Liver fibrosis: cellular mechanisms of progression and resolution.
Clin Sci (Lond).
2007;
112
265-280
145
Friedman S L.
Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury.
J Biol Chem.
2000;
275
2247-2250
146
Duffield J S, Forbes S J, Constandinou C M et al..
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair.
J Clin Invest.
2005;
115
56-65
147
Novobrantseva T I, Majeau G R, Amatucci A et al..
Attenuated liver fibrosis in the absence of B cells.
J Clin Invest.
2005;
115
3072-3082
148
Harris D P, Haynes L, Sayles P C et al..
Reciprocal regulation of polarized cytokine production by effector B and T cells.
Nat Immunol.
2000;
1
475-482
149
Safadi R, Ohta M, Alvarez C E et al..
Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes.
Gastroenterology.
2004;
127
870-882
150
Chiaramonte M G, Donaldson D D, Cheever A W, Wynn T A.
An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response.
J Clin Invest.
1999;
104
777-785
David AdamsM.D.
The Liver Research Group, MRC Centre for Immune Regulation, Institute for Biomedical Science, The University of Birmingham Medical School
Edgbaston, Birmingham B15 2TT, United Kingdom
Email: d.h.adams@bham.ac.uk